Weight Loss
Mfg : Novo NordiskWegovy
Prescription Injectable GLP-1 Medication Wegovy 0.25MG/0.5ML is a prescription medication used with a reduced-calorie diet and increased physical activity for weight management.
Starting Dose 0.25 mg is the initial dose for the first four weeks of treatment, administered once weekly
Once-Weekly Injection Administered subcutaneously once per week, on the same day each week
Multiple Strengths Available Available in 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg strengths for dose escalation
Prescription Only Available only with a valid prescription from a licensed healthcare provider
Disclaimer: The FDA may not have evaluated this product for safety, effectiveness, or quality.4 Weekly Doses
Per Dose $ 00.00
Total Price
Wegovy 0.25MG/0.5ML is a prescription injectable medication used with a reduced-calorie diet and increased physical activity for weight management. The information provided is for educational purposes only and does not replace professional medical advice.
Product Name: Wegovy 0.25MG/0.5ML
Category: Prescription Weight Management
Active Ingredient: Semaglutide
Available Strengths: 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, 2.4 mg/0.75 mL
Form: Prefilled, Single-Dose Pen for Subcutaneous Injection
Manufacturer: Novo Nordisk
Availability: Prescription only
Wegovy is taken once weekly, on the same day each week, at any time of day, with or without meals. The 0.25 mg dose is the starting dose for the first four weeks. The dosage is increased in a stepwise manner over subsequent months to the maintenance dose, as directed by your healthcare provider. Follow your healthcare providers specific instructions exactly.
Starting Dose: 0.25 mg is the initial dose for the first four weeks of treatment.
Once-Weekly Injection: Administered subcutaneously once per week.
Multiple Strengths Available: Available in 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg strengths.
Prescription Only: Available only with a valid prescription from a licensed healthcare provider.
Adults with obesity seeking prescription weight management
Adults with excess weight who also have weight-related medical problems
Children aged 12 years and older with obesity
Individuals under the care of a licensed healthcare provider
Wegovy is a prescription medication. A licensed healthcare provider must evaluate your medical history and current health status before prescribing.
Contraindications: Do not use if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Do not use if you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy.
Common Side Effects: The most common side effects may include nausea, diarrhea, vomiting, constipation, stomach pain, headache, tiredness, upset stomach, dizziness, feeling bloated, belching, gas, stomach flu, heartburn, and hair loss.
Serious Side Effects: Wegovy may cause serious side effects including possible thyroid tumors, including cancer, pancreatitis, gallbladder problems, hypoglycemia, acute kidney injury, severe gastrointestinal reactions, hypersensitivity reactions, diabetic retinopathy complications, increased heart rate, suicidal behavior and ideation, and pulmonary aspiration during anesthesia.
Precautions: Inform your healthcare provider of all medications you are taking and any medical conditions you have. Wegovy should be used with a reduced-calorie diet and increased physical activity.
Use Wegovy exactly as prescribed by your licensed healthcare provider. Follow all instructions for administration and dosing provided in the Instructions for Use. Do not exceed the prescribed dosage.
Store as directed by your healthcare provider or pharmacist. Keep out of reach of children. Dispose of used pens and needles in an FDA-cleared sharps disposal container. Do not share this medication with others.